RTTNews | Sep 21, 2020 09:11AM EDT

09:10 Monday, September 21, 2020 (RTTNews.com) - XBiotech Inc. (XBIT) said the company is developing a new therapy, FLUVID, for treating illness caused by combined infections with influenza and COVID-19. This therapy will combine XBiotech's influenza True Human antibodies together with its recently discovered COVID-19 antibodies into one treatment.

John Simard, XBiotech CEO, said: "We believe a combination antibody therapy is the best way to prepare for flu season or a larger influenza pandemic outbreak that may occur in combination with COVID-19. We now have candidate therapeutics to treat real-world infections which will involve multiple pathogens and co-infections."

Read the original article on RTTNews ( https://www.rttnews.com/3130178/xbiotech-developing-combination-antibody-therapy-for-influenza-covid-19-co-infections.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved